Opella Western Europe, excluding France

Certified B Corporation
Headquarters

Catalonia, Spain

Certified Since

June 2024

Industry

Pharmaceutical products

Sector

Wholesale/Retail

Operates In

Austria,

Belgium,

Germany,

Greece,

Italy,

Portugal,

Spain,

Switzerland,

United Kingdom

Opella Western Europe, excluding France (Opella Healthcare Italy Srl Società Benefit, A.Nattermann & Cie GmbH., Opella Healthcare UK Limited, Opella Healthcare Spain, SL, Opella Healthcare Unipessoal LDA, Opella Healthcare Switzerland AG (ex Pharmaton AG) CH, Opella Healthcare Austria GmbH, Opella Healthcare Belgium NV/SA and Opella Healthcare Greece single Member Ltd) offers a diverse product line of over-the-counter medicines, food supplements and medical devices across several categories, including digestive health, cough and cold, pain and mental health. Our strong portfolio of brands includes Dulcolax, Buscopan and Allegra. Through our consumer-led, science-based products we enable people to champion better self-care and are investing in community well-being, because we believe healthier people and a healthier planet go hand in hand. As guardians of personal health, we are dedicated to growing our business while helping improve the health of people and the planet.

Overall B Impact Score

Based on the B Impact assessment, Opella Western Europe, excluding France earned an overall score of 86.9. The median score for ordinary businesses who complete the assessment is currently 50.9.
86.9
86.9 Overall B Impact Score
80 Qualifies for B Corp Certification
50.9 Median Score for Ordinary Businesses

Governance 12.4

Governance evaluates a company's overall mission, engagement around its social/environmental impact, ethics, and transparency. This section also evaluates the ability of a company to protect their mission and formally consider stakeholders in decision making through their corporate structure (e.g. benefit corporation) or corporate governing documents.


Workers 28.4

Workers evaluates a company’s contributions to its employees’ financial security, health & safety, wellness, career development, and engagement & satisfaction. In addition, this section recognizes business models designed to benefit workers, such as companies that are at least 40% owned by non-executive employees and those that have workforce development programs to support individuals with barriers to employment.


Community 16.9

Community evaluates a company’s engagement with and impact on the communities in which it operates, hires from, and sources from. Topics include diversity, equity & inclusion, economic impact, civic engagement, charitable giving, and supply chain management. In addition, this section recognizes business models that are designed to address specific community-oriented problems, such as poverty alleviation through fair trade sourcing or distribution via microenterprises, producer cooperative models, locally focused economic development, and formal charitable giving commitments.


Environment 14.2

Environment evaluates a company’s overall environmental management practices as well as its impact on the air, climate, water, land, and biodiversity. This includes the direct impact of a company’s operations and, when applicable its supply chain and distribution channels. This section also recognizes companies with environmentally innovative production processes and those that sell products or services that have a positive environmental impact. Some examples might include products and services that create renewable energy, reduce consumption or waste, conserve land or wildlife, provide less toxic alternatives to the market, or educate people about environmental problems.


Customers 14.7

Customers evaluates a company’s stewardship of its customers through the quality of its products and services, ethical marketing, data privacy and security, and feedback channels. In addition, this section recognizes products or services that are designed to address a particular social problem for or through its customers, such as health or educational products, arts & media products, serving underserved customers/clients, and services that improve the social impact of other businesses or organizations.



Previous Overall B Impact Scores

2024 Overall B Impact Score86.9

Additional Documentation

Sanofi Consumer Healthcare Western Europe, excluding France - Transparent Assessment 2024

Sanofi Consumer Healthcare Western Europe, excluding France - Disclosure Report 2024

Sanofi Consumer Healthcare Western Europe, excluding France - Pharmaceutical Industry Disclosure 2024

Sanofi Consumer Healthcare Germany - Disclosure Report 2023

Sanofi Consumer Healthcare Germany - Transparent Assessment 2023

Sanofi Consumer Healthcare Germany - Pharmaceutical Industry Disclosure 2023

Sanofi Consumer Healthcare Italy - Disclosure Report 2023

Sanofi Consumer Healthcare Italy - Transparent Assessment 2023

Sanofi Consumer Healthcare Italy - Pharmaceutical Industry Disclosure 2023

Sanofi Consumer Healthcare Western Europe, excluding France - Score Aggregation Methodology & Brand List 2024


B Labs Logo - Home Link

Sign up to our Insights newsletter, a monthly digest of the latest news on economic systems change from B Lab Global.

We take the security of your data seriously, read our privacy policy for further information. For newsletter communications relating to your local region, please visit Global Partner sites to subscribe.

Copyright © 2024 B Lab. All rights reserved.